Lena Lapkina-Gendler Selected Research

Laron Syndrome (Syndrome, Laron)

12/2021	The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.
7/2019	Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer.
1/2019	Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways.
1/2018	Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence.
1/2018	Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lena Lapkina-Gendler Research Topics

Disease

5	Laron Syndrome (Syndrome, Laron) 12/2021 - 01/2018
5	Neoplasms (Cancer) 12/2021 - 01/2016
2	Insulin-Like Growth Factor I Deficiency 12/2021 - 01/2019
2	Dwarfism 12/2021 - 07/2019
2	Endometrial Neoplasms (Endometrial Cancer) 12/2021 - 07/2019
1	Uterine Neoplasms (Uterine Cancer) 12/2021
1	Growth Disorders 01/2018

Drug/Important Bio-Agent (IBA)

4	Insulin (Novolin)FDA Link 12/2021 - 01/2016
3	Insulin-Like PeptidesIBA 07/2019 - 01/2018
3	Growth Hormone (Somatotropin)IBA 01/2018 - 01/2016
2	Somatotropin Receptors (Growth Hormone Receptor)IBA 12/2021 - 07/2019
1	Odorant Receptors (Odorant Receptor)IBA 12/2021
1	ORALIT (ORS)IBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	Biological ProductsIBA 07/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018